An Interview with Kelsey Moody: Developing a company to end age-related diseases
Recently, we attended the Longevity Leaders Conference held in London, and spoke with Kelsey Moody. She is the CEO of Ichor Therapeutics. This company focuses on age-related illnesses by targeting the aging process itself. It was a great opportunity to see what his company has been up to since we interviewed him in 2017.
Ich thought that it was about time we updated ourselves on the progress of Ichor and its Portfolio companies. What is the current state of affairs for the Ichor Group?
Ichor had a great year in 2018. Our portfolio raised more than $16 million, which allowed us to expand all aspects of the business. Over 50 people are now working for us, mainly bench scientists and researchers. We’re achieving our goal to be a vertically-integrated biopharmaceutical firm.
Source:
https://www.leafscience.org/an-interview-with-kelsey-moody-developing-a-company-to-end-age-related-diseases/
